alexa Recombinant fibroblast growth protein enhances healing ability of experimentally induced tendon injury in vivo.
Pharmaceutical Sciences

Pharmaceutical Sciences

Biochemistry & Pharmacology: Open Access

Author(s): Oryan A, Moshiri A

Abstract Share this page

Abstract This study was designed to investigate the effects of recombinant human basic fibroblast growth factor (bFGF) on a complete superficial digital flexor tendon (SDFT) rupture after surgical repair in rabbits. Eighty mature New Zealand White rabbits of both sexes were randomly divided into two equal groups: Treated and Control. Each group was subdivided into two 28- and 84-day post-injury subgroups. After tenotomy and surgical repair, the animals were immobilized for 14 days. In the treated group, bFGF was directly applied subcutaneously over the lesion on days 3, 7 and 10 after injury. The control animals received normal saline injection of the same viscosity and volume and at the same intervals. Ultrasonographical observations were conducted at weekly intervals. The animals were euthanized at 28 and 84 days after injury. The tendons were evaluated at macroscopic, histopathologic and ultrastructural levels and were assessed for biomechanical and percentage dry weight parameters. Compared to injured control animals, treated animals showed a decrease in the diameter of the injured tendon and peritendinous adhesion as well as increased tenoblast proliferation, collagen production and ultimate strength of the injured tendons (p < 0.005). At 84 days after injury, treatment resulted in enhanced maturation of the cellular and collagen elements and improved tissue alignment and density. These improvements resulted in increased biomechanical performance of the injured tendons compared to controls (p = 0.001). bFGF showed promising curative effects on restoration of the biomechanical and morphological properties of the ruptured SDFT in rabbits and may be applicable in clinical studies. Copyright © 2012 John Wiley & Sons, Ltd. This article was published in J Tissue Eng Regen Med and referenced in Biochemistry & Pharmacology: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords